Sanofi's Q3 earnings surged, with a 14.4% increase in income to €4.61 billion, led by Dupixent and new launches. Revenue beat ...
French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted ...
French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, helped by ...